Details for New Drug Application (NDA): 209919
✉ Email this page to a colleague
The generic ingredient in OLOPATADINE HYDROCHLORIDE is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 209919
Tradename: | OLOPATADINE HYDROCHLORIDE |
Applicant: | Alembic |
Ingredient: | olopatadine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 209919
Mechanism of Action | Histamine H1 Receptor Antagonists |
Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for 209919
Suppliers and Packaging for NDA: 209919
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 209919 | ANDA | Alembic Pharmaceuticals Limited | 46708-709 | 46708-709-05 | 1 BOTTLE in 1 CARTON (46708-709-05) / 5 mL in 1 BOTTLE |
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 209919 | ANDA | Alembic Pharmaceuticals Inc. | 62332-501 | 62332-501-05 | 1 BOTTLE, PLASTIC in 1 CARTON (62332-501-05) / 5 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.1% BASE | ||||
Approval Date: | Dec 7, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription